BACKGROUNDPregnancy-induced hypertension is one of the leading causes of foetal and maternal morbidity and mortality worldwide. In our country, the prevalence of the disease is 5-15% and perinatal death rate due to PIH is 20%. Early detection becomes very essential as the disease is detected in advanced stages most of the times. Hence, screening for the prediction of PIH becomes necessary for improving maternal and foetal outcome. Aims-To evaluate the relationship between placental location and occurrence of PIH. To determine whether placental location can be used as a screening test for detection of PIH and to study maternal and foetal outcome in these patients. MATERIALS AND METHODSPrimigravidae with singleton pregnancy, without any medical disorder were considered for the study and were subjected to ultrasound examination to scan for gestational age, placental localisation-Central or lateral, amount of liquor amnii, congenital anomalies. The location of placenta was determined around or more than 24 weeks of gestation with real time ultrasound and repeat ultrasound was done in some patients at a later gestation to confirm the placental location. All patients with unilateral placenta on scan were followed up to delivery and the early detection of PIH reported, also the maternal and neonatal outcome was studied at delivery. Measurements were obtained & reported. The relationship between laterality of placenta and occurrence of PIH noted and discussed. Statistical Analysis Used-Statistical analysis was done using percentages and Chi-square test. Settings and Design-This was a prospective study conducted over a period of 6 months from September 2015 to February 2016 in the Department of Obstetrics and Gynaecology, SMBT Institute of Medical Sciences, Dhamangaon, Nasik. RESULTSThe present study showed the incidence of PIH in primigravidae to be 15.24% and incidence of lateral placentation in primigravidae being 15.8%. Our study also shows that 63 out of 83 primigravidae with lateral placenta developed PIH and 17 out of 425 primigravidae without lateral placenta developed PIH. The sensitivity and specificity of our study being 75.9% and 96.15% respectively. CONCLUSIONEvidence of lateral placenta on ultrasonography is a very useful addition to our armamentarium of antepartum testing for prediction of PIH and its management. Placental localisation has a definite potential to serve as a simple, non-invasive screening test for prediction of PIH. KEYWORDSPlacenta, Pregnancy-induced Hypertension. HOW TO CITE THIS ARTICLE: Naik SN, Naik AS, Phadol VA. Role of placental localisation in prediction of pregnancy induced hypertension. J. Evolution Med. Dent. Sci. 2017;6(20):1600-1602, DOI: 10.14260/Jemds/2017/351 BACKGROUND Pregnancy-induced hypertension (PIH) still remains one of the leading causes of foetal and maternal morbidity and mortality. In our country, the prevalence of the disease is 5-15% 1 and perinatal death rate due to PIH is 20%. Early detection becomes very essential as the disease is detected in advan...
BACKGROUNDEntanglement of umbilical cord around the foetal neck (Nuchal cord) is a common finding at delivery. It is often assumed that nuchal cord causes cord compression and thus low birth weight and is often cited as major cause of foetal distress, intrapartum complications and perinatal mortality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.